| 000 | 01756 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515192506.0 | ||
| 264 | 0 | _c20100303 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2009.09.135 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBernstein, David I | |
| 245 | 0 | 0 |
_aRandomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers. _h[electronic resource] |
| 260 |
_bVaccine _cDec 2009 |
||
| 300 |
_a484-93 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Neutralizing _ximmunology |
| 650 | 0 | 4 |
_aAntibody Formation _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Viral _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity, Cellular _ximmunology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aReap, Elizabeth A | |
| 700 | 1 | _aKaten, Kevin | |
| 700 | 1 | _aWatson, Aubrey | |
| 700 | 1 | _aSmith, Kaitlin | |
| 700 | 1 | _aNorberg, Pamela | |
| 700 | 1 | _aOlmsted, Robert A | |
| 700 | 1 | _aHoeper, Amy | |
| 700 | 1 | _aMorris, John | |
| 700 | 1 | _aNegri, Sarah | |
| 700 | 1 | _aMaughan, Maureen F | |
| 700 | 1 | _aChulay, Jeffrey D | |
| 773 | 0 |
_tVaccine _gvol. 28 _gno. 2 _gp. 484-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2009.09.135 _zAvailable from publisher's website |
| 999 |
_c19247349 _d19247349 |
||